Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocyclic compound as CDK-HDAC double-channel inhibitor

Heterocyclic compound as CDK-HDAC double-channel inhibitor

US Patent 12415797 · Granted Sep 16, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic comipound as CDK-HDAC dual pathway inhibitor2025
Heterocyclic comipound as CDK-HDAC dual pathway inhibitor2025
Heterocyclic comipound as CDK-HDAC dual pathway inhibitor2025
Verification method, electronic device, and non-transitory computer-readable sto2025
Thermoelectric materials synthesized by self-propagating high temperature synthe2022
Heterocyclic compound serving as FGFR4 inhibitor2022
Heterocyclic compound serving as FGFR4 inhibitor2022
Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor2022
Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor2022
Heterocycles useful as anti-cancer agents2022
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor2021
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor2021